Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (668) 668
Publication (60) 60
Patent (25) 25
Book Chapter (12) 12
Book / eBook (9) 9
Book Review (4) 4
Web Resource (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (398) 398
index medicus (338) 338
tuberculosis (269) 269
infectious diseases (211) 211
female (116) 116
microbiology (114) 114
infectious disease (104) 104
male (104) 104
adult (91) 91
medicine, general & internal (86) 86
respiratory system (85) 85
mycobacterium-tuberculosis (83) 83
pulmonary tuberculosis (79) 79
antitubercular agents - therapeutic use (78) 78
diagnosis (77) 77
immunology (73) 73
abridged index medicus (69) 69
public health (69) 69
global health (66) 66
pulmonary/respiratory (65) 65
infections (62) 62
infectious and parasitic diseases (57) 57
tuberculosis - prevention & control (57) 57
drug resistance (56) 56
mortality (56) 56
epidemiology (54) 54
health aspects (54) 54
middle aged (54) 54
tuberculosis - epidemiology (54) 54
infection (50) 50
tuberculosis - diagnosis (50) 50
tuberculosis - drug therapy (47) 47
risk factors (46) 46
research (45) 45
mycobacterium tuberculosis (44) 44
care and treatment (43) 43
hiv (43) 43
internal medicine (41) 41
tuberculosis, multidrug-resistant - drug therapy (40) 40
hospitals (39) 39
medicine (37) 37
adolescent (36) 36
human immunodeficiency virus--hiv (36) 36
mycobacterium tuberculosis - immunology (36) 36
antitubercular agents (35) 35
disease (35) 35
medical research (34) 34
patients (34) 34
world health organization (34) 34
animals (33) 33
hiv infections - complications (33) 33
mycobacterium tuberculosis - drug effects (33) 33
prevalence (32) 32
public, environmental & occupational health (32) 32
surveillance (32) 32
treatment outcome (32) 32
tuberculosis, pulmonary - diagnosis (32) 32
child (31) 31
sensitivity and specificity (30) 30
analysis (29) 29
tuberculosis - immunology (29) 29
aged (28) 28
critical care medicine (28) 28
drug therapy (28) 28
multidrug-resistant tuberculosis (28) 28
children (27) 27
vaccines (27) 27
clinical trials (26) 26
epidemics (26) 26
developing countries (25) 25
human necessities (25) 25
hygiene (25) 25
medical colleges (25) 25
medical or veterinary science (25) 25
polymerase chain reaction (25) 25
preparations for medical, dental, or toilet purposes (25) 25
prevention (25) 25
research article (25) 25
tuberculosis, multidrug-resistant - epidemiology (25) 25
coronavirus infections - epidemiology (24) 24
drug resistance in microorganisms (24) 24
young adult (24) 24
a300 clinical medicine (23) 23
control (23) 23
disease outbreaks (23) 23
incidence (23) 23
saudi-arabia (23) 23
studies (23) 23
tropical medicine (23) 23
tuberculosis, multidrug-resistant - diagnosis (23) 23
antigens (22) 22
biomarkers (22) 22
communicable diseases (22) 22
immune response (22) 22
pneumonia (22) 22
sub-saharan africa (22) 22
zambia (22) 22
africa (21) 21
mycobacterium tuberculosis - isolation & purification (21) 21
outbreak (21) 21
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (709) 709
Portuguese (7) 7
French (6) 6
Finnish (3) 3
German (3) 3
Swedish (3) 3
Norwegian (2) 2
Danish (1) 1
Hungarian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Lifeline: Alimuddin Zumla
by Alimuddin Zumla
The Lancet, ISSN 0140-6736, 06/2003, Volume 361, Issue 9374, p. 2092
  Alimuddin Zumla is Professor of Infectious Diseases and International Health at University College London, London, UK, and Consultant Infectious Diseases... 
Disease | Educators
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Current trends and newer concepts on diagnosis, management and prevention of respiratory tract infections
by Zumla, Alimuddin
Current Opinion in Pulmonary Medicine, ISSN 1070-5287, 05/2013, Volume 19, Issue 3, pp. 189 - 191
SYSTEMATIC ANALYSIS | GLOBAL BURDEN | 21 REGIONS | RESPIRATORY SYSTEM | DISEASE | Respiratory Tract Infections - therapy | Respiratory Tract Infections - diagnosis | Humans | Respiratory Tract Infections - prevention & control | Edited by Alimuddin Zumla | INFECTIOUS DISEASES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Tuberculosis
by Lawn, Stephen D, MRCP and Zumla, Alimuddin I, Prof
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9785, pp. 57 - 72
Summary Tuberculosis results in an estimated 1·7 million deaths each year and the worldwide number of new cases (more than 9 million) is higher than at any... 
Internal Medicine | MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, GENERAL & INTERNAL | RESOURCE-LIMITED SETTINGS | RECONSTITUTION INFLAMMATORY SYNDROME | SUB-SAHARAN AFRICA | MULTIDRUG-RESISTANT TUBERCULOSIS | HIV-ASSOCIATED TUBERCULOSIS | ACID AMPLIFICATION TESTS | PULMONARY TUBERCULOSIS | ANTIRETROVIRAL THERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS | Global Health | Humans | Risk Factors | Biomarkers - analysis | Europe - epidemiology | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Tuberculosis, Multidrug-Resistant - epidemiology | Tuberculosis, Pulmonary - complications | Host-Pathogen Interactions | Tuberculosis, Pulmonary - diagnosis | HIV Infections - complications | Mycobacterium tuberculosis - physiology | Tuberculosis, Pulmonary - epidemiology | Africa South of the Sahara - epidemiology | Complications and side effects | Care and treatment | Wellness programs | Usage | Tuberculosis | Research | Diagnosis | Biomarkers | Epidemiology | Nitric oxide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. The return of the white plague
: global poverty and the 'new' tuberculosis
by Gandy, Matthew and Zumla, Alimuddin
2003, ISBN 9781859846698, vi, 330
Medical policy | Tuberculosis | Poverty
Book
Details down arrow
5. Full Text Middle East respiratory syndrome
by Zumla, Alimuddin, Prof and Hui, David S, Prof and Perlman, Stanley, Prof
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9997, pp. 995 - 1007
Summary Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel single-stranded, positive-sense RNA betacoronavirus... 
Internal Medicine | DROMEDARY CAMELS | MEDICINE, GENERAL & INTERNAL | NEUTRALIZING ANTIBODIES | IMMUNE-RESPONSES | CLINICAL-ASPECTS | TO-HUMAN TRANSMISSION | MERS-COV | SYNDROME CORONAVIRUS INFECTION | CRITICALLY-ILL PATIENTS | FUNCTIONAL RECEPTOR | SAUDI-ARABIA | Epidemics | Coronavirus Infections - diagnosis | Humans | Middle Aged | Child, Preschool | Infant | Male | Coronavirus Infections - transmission | Middle East | Young Adult | Camelus - virology | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Animals | Coronavirus Infections - epidemiology | Coronavirus Infections - therapy | Adolescent | Aged, 80 and over | Adult | Female | Aged | Child | Saudi Arabia | Acute respiratory distress syndrome | Comorbidity | Mortality | United Kingdom | Respiratory agents | Health aspects | Disease prevention | Viruses | Respiratory diseases | Prevention | Coronavirus | Treatment | Pathogenesis | Clinical | MERS-CoV | MERS | Middle East Respiratory Syndrome | Epidemiology | Public health | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Tuberculosis
: a subject collection from Cold Spring Harbor perspectives in medicine
by Zumla, Alimuddin, editor and Rubin, Eric J., editor and Kaufmann, S. H. E. editor. (Stefan H. E.)
2015, ISBN 1621820734, xii, 655
Mycobacterium tuberculosis | Tuberculosis
Book
Details down arrow
7. Full Text Advances in the development of new tuberculosis drugs and treatment regimens
by Zumla, Alimuddin and Nahid, Payam and Cole, Stewart T
Nature Reviews Drug Discovery, ISSN 1474-1776, 05/2013, Volume 12, Issue 5, pp. 388 - 404
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid, rifampicin, pyrazinamide and ethambutol) treatment regimen,... 
IN-VITRO | RESISTANT TUBERCULOSIS | ATP SYNTHASE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | EARLY BACTERICIDAL ACTIVITY | PULMONARY TUBERCULOSIS | BENZOTHIAZINONES | PHARMACOLOGY & PHARMACY | ANTIRETROVIRAL THERAPY | DOSE RIFAMPIN | MOXIFLOXACIN | KILL MYCOBACTERIUM-TUBERCULOSIS | Drug Evaluation, Preclinical - trends | Humans | Drug Discovery - trends | Clinical Trials as Topic | Mycobacterium tuberculosis - drug effects | Anti-Bacterial Agents - therapeutic use | Clinical Trials, Phase III as Topic | Drug Resistance, Multiple, Bacterial | Tuberculosis - drug therapy | Biomarkers | Research Design | Drug Combinations | Antitubercular Agents - therapeutic use | Clinical Trials, Phase II as Topic | Mycobacterium tuberculosis - genetics | Control | Tuberculosis | Demographic aspects | Causes of | Clinical trials | Antitubercular agents | Product development | Forecasts and trends | Research | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
by Caminero, José A, Dr and Sotgiu, Giovanni, PhD and Zumla, Alimuddin, FRCP and Migliori, Giovanni Battista, MD
Lancet Infectious Diseases, The, ISSN 1473-3099, 2010, Volume 10, Issue 9, pp. 621 - 629
Summary Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally thought to have high mortality rates. However, many cases can... 
Infectious Disease | MYCOBACTERIUM-TUBERCULOSIS | INVITRO ACTIVITY | TUBERCLE-BACILLI | INFECTIOUS DISEASES | EARLY BACTERICIDAL ACTIVITY | TREATMENT OUTCOMES | CROSS-RESISTANCE | MDR-TB | XDR-TB | CLAVULANIC ACID | RPOB MUTATIONS | Extensively Drug-Resistant Tuberculosis - drug therapy | Levofloxacin | Drug Resistance, Multiple | Humans | Ofloxacin - therapeutic use | Fluoroquinolones - therapeutic use | Kanamycin - therapeutic use | Pyrazinamide - therapeutic use | Capreomycin - therapeutic use | Amikacin - therapeutic use | Antitubercular Agents - classification | Tuberculosis - drug therapy | Antitubercular Agents - standards | Isoniazid - therapeutic use | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Drugs | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Amoxicillin | Antitubercular agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Tuberculosis : a comprehensive clinical reference
by Zumla, Alimuddin I and Schaaf, H. Simon
2009, ISBN 1416039880, xxvi, 1014
This book provides all the vital information you need to know about tuberculosis, especially in the face of drug-resistant strains of the disease. Coverage... 
Tuberculosis | Treatment | Pathophysiology | Epidemiology
Book
Details down arrow
10. Full Text Tuberculosis
by Zumla, Alimuddin and Raviglione, Mario and Hafner, Richard and Fordham von Reyn, C
The New England Journal of Medicine, ISSN 0028-4793, 02/2013, Volume 368, Issue 8, pp. 745 - 755
In 2011, there were 8.7 million new cases of active tuberculosis worldwide. Recent advances in diagnostics, drugs, and vaccines and enhanced implementation of... 
BCG Vaccine | Tuberculosis, Pulmonary - diagnosis | Humans | HIV Infections - complications | Mycobacterium tuberculosis - physiology | Isoniazid - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Virus Activation | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Tuberculosis, Pulmonary - complications | Usage | Care and treatment | Tuberculosis vaccines | Tuberculosis | Medical case management | Directly observed therapy | Causes of | Tuberculin test | Diagnosis | Drug therapy | Methods | Infections | Human immunodeficiency virus--HIV | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Tropical lung disease
by Sharma, Om P and Zumla, Alimuddin
2002, Clinics in chest medicine, Volume 23, no. 2., xvii, 528
Book
Details down arrow
12. Full Text Epidemiology and clinical management of Legionnaires' disease
by Phin, Nick, Prof and Parry-Ford, Frances, MSc and Harrison, Timothy, PhD and Stagg, Helen R, PhD and Zhang, Natalie, MB and Kumar, Kartik, MB and Lortholary, Olivier, Prof and Zumla, Alimuddin, Prof and Abubakar, Ibrahim, Prof
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 10, pp. 1011 - 1021
Summary Legionnaires' disease is an important cause of community-acquired and hospital-acquired pneumonia. Although uncommon, Legionnaires' disease continues... 
Infectious Disease | LEGIONELLA-PNEUMOPHILA PNEUMONIA | INFECTIOUS DISEASES | COMMUNITY-ACQUIRED PNEUMONIA | HOSPITALIZED-PATIENTS | RISK-FACTORS | NEW-ZEALAND | PONTIAC FEVER | LONGBEACHAE SEROGROUP 1 | URINARY ANTIGEN | SEQUENCE TYPES | COOLING-TOWERS | Legionnaires' Disease - epidemiology | Global Health | Disease Outbreaks | Legionnaires' Disease - diagnosis | Legionnaires' Disease - transmission | Bacterial Typing Techniques | Humans | Virulence | Legionella pneumophila - classification | Legionella pneumophila - pathogenicity | Legionella pneumophila - isolation & purification | Legionnaires' Disease - therapy | Epidemics | Pneumonia | Hospitals | Bacterial pneumonia | Bacteria | Virulence (Microbiology) | Health aspects | Epidemiology | Public health | Cooling | Mortality | Fountains | Infections | Legionnaires disease | Patients | Resorts & spas | Surveillance | Aerosols | Fatalities
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Treating drug-resistant tuberculosis
by Zumla, Alimuddin
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 4, pp. 280 - 280
Infectious Disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights